Szeto Jennifer Y Y, Walton Courtney C, Rizos Alexandra, Martinez-Martin Pablo, Halliday Glenda M, Naismith Sharon L, Chaudhuri K Ray, Lewis Simon J G
1Parkinson's Disease Research Clinic, Brain and Mind Centre and Central Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, NSW Australia.
2Parkinson Foundation International Centre of Excellence, King's College Hospital and Kings College London, London, UK.
NPJ Parkinsons Dis. 2020 Jan 7;6:2. doi: 10.1038/s41531-019-0106-4. eCollection 2020.
While several studies have investigated the clinical progression of cognitive decline in Parkinson's disease (PD) patients, there has been a paucity of data on specifically evaluating PD patients with a disease duration of over 20 years. This study retrospectively investigated the frequency of dementia in PD (PDD) patients with a disease duration of over 20 years assessed in research clinics across the UK and Australia. Data from 2327 PD patients meeting the United Kingdom Parkinson's Disease Society Brain Bank Criteria was pooled. A diagnosis of probable PDD was made according to the Movement Disorder Society Level 1 criteria. Thirty-six participants had a disease duration of at least 20 years. Of the 36 patients, only 7 (19%) were classified as probable PDD. Compared to PD patients without dementia, those with dementia had lower levels of educational attainment and exhibited more severe motor features. Additionally, 34 out of the 36 patients (94%) exhibited a non-tremor dominant phenotype. No significant differences in age, age onset, disease duration, dopaminergic medication use, and sex distribution were observed between PD patients with and without dementia. Findings from the present study suggest that the prevalence of dementia in long-term PD patients may be lower than anticipated and suggest that the trajectory of cognitive decline in PD patients can be different. These findings highlight the need to investigate factors that might affect the outcome of cognitive decline in long-term PD patients, which may lead to the determination of potential modulating factors in the development of dementia in these patients.
虽然已有多项研究调查了帕金森病(PD)患者认知功能下降的临床进展情况,但针对病程超过20年的PD患者进行专门评估的数据却很匮乏。本研究回顾性调查了在英国和澳大利亚各研究诊所评估的病程超过20年的PD患者中痴呆症的发生率。汇总了2327例符合英国帕金森病协会脑库标准的PD患者的数据。根据运动障碍协会1级标准做出可能的帕金森病痴呆症(PDD)诊断。36名参与者病程至少20年。在这36例患者中,只有7例(19%)被归类为可能的PDD。与无痴呆症的PD患者相比,有痴呆症的患者受教育程度较低,运动特征更严重。此外,36例患者中有34例(94%)表现为非震颤为主的表型。在有痴呆症和无痴呆症的PD患者之间,未观察到年龄、发病年龄、病程、多巴胺能药物使用及性别分布方面的显著差异。本研究结果表明,长期PD患者中痴呆症的患病率可能低于预期,并表明PD患者认知功能下降的轨迹可能不同。这些发现凸显了调查可能影响长期PD患者认知功能下降结果的因素的必要性,这可能有助于确定这些患者痴呆症发展过程中的潜在调节因素。